B. Larsen

发表

Genome‐Wide Association Studies in Apple Reveal Loci for Aroma Volatiles, Sugar Composition, and Harvest Date

S. Myles, M. Petersen, T. Toldam-Andersen, 2019, The plant genome.

Inhibition of Cx43 gap junction uncoupling prevents high glucose‐induced apoptosis and reduces excess cell monolayer permeability in retinal vascular endothelial cells

B. Larsen, U. Mouritzen, Dongjoon Kim, 2018, Experimental eye research.

Effects of the New Antiarrhythmic Peptide ZP123 on Epicardial Activation and Repolarization Pattern

F. Mohr, S. Dhein, B. Larsen, 2003, Cell communication & adhesion.

The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus

M. Christensen, F. Knop, B. Larsen, 2014, Expert opinion on drug discovery.

Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia

M. Lo, Yenn-Jiang Lin, Shih‐Ann Chen, 2020, PloS one.

Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts.

B. Larsen, Shien‐Fong Lin, Chen-Ying Hung, 2016, Heart rhythm.

Stability, metabolism and transport of D-Asp(OBzl)-Ala--a model prodrug with affinity for the oligopeptide transporter.

H. Lennernäs, S. Frokjaer, B. Larsen, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21.

P. Govoni, V. Locatelli, A. Torsello, 2012, The Biochemical journal.

Glucagon-Like Peptide 1 Receptor Agonist ZP10A Increases Insulin mRNA Expression and Prevents Diabetic Progression in db/db Mice

B. Larsen, S. Neve, J. Petersen, 2003, Journal of Pharmacology and Experimental Therapeutics.

Glucagon-Like Peptide 1 Receptor Agonist ZP 10 A Increases Insulin mRNA Expression and Prevents Diabetic Progression in db / db Mice

B. Larsen, S. Neve, J. Petersen, 2003 .

Pharmacological Characterization of the New Stable Antiarrhythmic Peptide Analog Ac-d-Tyr-d-Pro-d-Hyp-Gly-d-Ala-Gly-NH2 (ZP123): In Vivo and in Vitro Studies

B. Larsen, J. Petersen, A. Kjølbye, 2003, Journal of Pharmacology and Experimental Therapeutics.

Design and characterization of the first peptidomimetic molecule that prevents acidification-induced closure of cardiac gap junctions.

B. Larsen, S. Taffet, M. Delmar, 2010, Heart rhythm.

Novel Pharmacophores of Connexin43 Based on the “RXP” Series of Cx43-Binding Peptides

P. Sorgen, B. Larsen, S. Taffet, 2009, Circulation research.

N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: synthesis, chemical and enzymatic stability studies.

S. Frokjaer, B. Larsen, M. Fich, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs

R. Schaub, J. Keith, B. Larsen, 2006, Journal of Pharmacology and Experimental Therapeutics.

Prodrugs of peptides obtained by derivatization of the C-terminal peptide bond in order to effect protection against degradation by carboxypeptidases

S. Frokjaer, B. Larsen, A. Bak, 1996 .

β-Carboxylic acid esterified D-Asp-Ala retains a high affinity for the oligopeptide transporter in Caco-2 monolayers

S. Frokjaer, B. Larsen, M. Taub, 1997 .

A high-throughput method for genotyping S-RNase alleles in apple

T. Toldam-Andersen, C. Pedersen, B. Larsen, 2016, Molecular Breeding.

4.19 – 1,2,3,4-Thiatriazoles

B. Larsen, A. Holm, 1996 .

4.20 – 1,2,3,5-Thiatriazoles

B. Larsen, A. Holm, 1996 .